ALK Protein

ALK Protein

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">ALK</th></tr> [@stynen2015]
<tr><td><strong>Protein Name</strong></td><td>Anaplastic Lymphoma Kinase</td></tr>
<tr><td><strong>Gene</strong></td><td><a href="/genes/alk">ALK</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q9UHB8">Q9UHB8</a></td></tr>
<tr><td><strong>Protein Family</strong></td><td>Insulin receptor family</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~200 kDa (full-length)</td></tr>
<tr><td><strong>Expression</strong></td><td>Brain (neurons), lymphoid tissue</td></tr>
<tr><td><strong>Function</strong></td><td>Receptor tyrosine kinase, neural development</td></tr>
</table>
</div>

Overview

ALK (Anaplastic Lymphoma Kinase) is a receptor tyrosine kinase encoded by the [ALK](/genes/alk) gene. Originally discovered in anaplastic large cell lymphoma (ALCL), ALK is expressed primarily in the nervous system during development and in certain neuronal populations in adults. ALK plays crucial roles in neural development, synaptic plasticity, and has been implicated in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and ALS [1].

Structure and Activation

Receptor Architecture

ALK Protein

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">ALK</th></tr> [@stynen2015]
<tr><td><strong>Protein Name</strong></td><td>Anaplastic Lymphoma Kinase</td></tr>
<tr><td><strong>Gene</strong></td><td><a href="/genes/alk">ALK</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q9UHB8">Q9UHB8</a></td></tr>
<tr><td><strong>Protein Family</strong></td><td>Insulin receptor family</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~200 kDa (full-length)</td></tr>
<tr><td><strong>Expression</strong></td><td>Brain (neurons), lymphoid tissue</td></tr>
<tr><td><strong>Function</strong></td><td>Receptor tyrosine kinase, neural development</td></tr>
</table>
</div>

Overview

ALK (Anaplastic Lymphoma Kinase) is a receptor tyrosine kinase encoded by the [ALK](/genes/alk) gene. Originally discovered in anaplastic large cell lymphoma (ALCL), ALK is expressed primarily in the nervous system during development and in certain neuronal populations in adults. ALK plays crucial roles in neural development, synaptic plasticity, and has been implicated in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and ALS [1].

Structure and Activation

Receptor Architecture

ALK is a type I transmembrane receptor:

• Extracellular domain: Mam domain for ligand binding (with identified ligand pleiotrophin)
• Transmembrane helix: Single pass
• Juxtamembrane region: Contains activation loop
• Kinase domain: Catalytic tyrosine kinase activity
• C-terminal tail: Contains multiple phosphorylation sites

Activation Mechanisms

ALK can be activated by:

Oncogenic Mutations

In cancer, ALK can be constitutively activated through:

• Chromosomal translocations (NPM1-ALK, EML4-ALK)
• Point mutations (activating)
• Gene amplification

Expression and Function in the Brain

Developmental Expression

During nervous system development, ALK is highly expressed:

• Neural progenitor cells
• Developing [neurons](/entities/neurons)
• Axonal guidance pathways
• Synaptogenesis

Adult Brain Expression

In adult brains, ALK expression persists in:

• Specific neuronal populations
• Hippocampal neurons
• Cortical layers
• Cerebellar Purkinje cells

Neurotrophic Functions

ALK signaling provides neurotrophic support:

• Neuronal survival: Prevents [apoptosis](/entities/apoptosis)
• Differentiation: Promotes neuronal maturation
• Axonal growth: Supports axon guidance
• Synaptic plasticity: Modulates synaptic function

ALK in Neurodegenerative Diseases

Alzheimer's Disease

In [Alzheimer's disease](/diseases/alzheimers-disease), ALK may play complex roles:

Neuroprotection

Evidence for ALK-mediated neuroprotection:

• Activation promotes neuronal survival
• May protect against amyloid toxicity
• Modulates [tau](/proteins/tau) phosphorylation pathways

Therapeutic Potential

ALK-targeted approaches for AD:

• ALK agonists to enhance neurotrophic support
• Combination with other growth factors
• Modulation of synaptic function

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), ALK signaling may:

ALS and Other Disorders

ALK has been implicated in:

• Amyotrophic lateral sclerosis (ALS)
• Schizophrenia (genetic associations)
• Autism spectrum disorders

ALK Ligands in Neurodegeneration

Pleiotrophin (PTN)

PTN is a neurotrophic factor that activates ALK:

• Expressed in the brain
• Promotes neural repair
• Levels altered in neurodegenerative diseases

Midkine (MK)

Another ALK ligand:

• Developmental expression
• Neuroprotective properties
• Upregulated in injury

Therapeutic Targeting

ALK Agonists

ALK activation may provide therapeutic benefits:

• Small molecule ALK activators
• PTN/MK mimetics
• Gene therapy approaches

ALK Inhibitors

Cancer-approved ALK inhibitors include:

• Crizotinib
• Alectinib
• Lorlatinib

Summary

ALK is a receptor tyrosine kinase expressed in the nervous system with important roles in neural development, synaptic plasticity, and neuronal survival. While best known for its oncogenic role in lymphomas, ALK provides essential neurotrophic support to neurons and may be relevant to neurodegenerative diseases including Alzheimer's and Parkinson's disease. Targeting ALK signaling represents a potential therapeutic strategy for enhancing neuronal survival in these conditions.

See Also

• [ALK Gene](/genes/alk)
• [Alzheimer's disease](/diseases/alzheimers-disease)
• [Parkinson's disease](/diseases/parkinsons-disease)

External Links

• [GeneCards: ALK](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ALK)

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Phase-Separated Organelle Targeting](/hypothesis/h-ec731b7a) — <span style="color:#81c784;font-weight:600">0.72</span> · Target: G3BP1
• [Metabolic Circuit Breaker via Lipid Droplet Modulation](/hypothesis/h-3d993b5d) — <span style="color:#81c784;font-weight:600">0.66</span> · Target: PLIN2
• [Temporal Decoupling via Circadian Clock Reset](/hypothesis/h-019ad538) — <span style="color:#81c784;font-weight:600">0.65</span> · Target: CLOCK
• [Synthetic Biology Rewiring via Orthogonal Receptors](/hypothesis/h-e3506e5a) — <span style="color:#ffd54f;font-weight:600">0.59</span> · Target: CNO
• [Biorhythmic Interference via Controlled Sleep Oscillations](/hypothesis/h-49791706) — <span style="color:#ffd54f;font-weight:600">0.54</span> · Target: GABRA1
• [Extracellular Matrix Stiffness Modulation](/hypothesis/h-725c62e9) — <span style="color:#ffd54f;font-weight:600">0.53</span> · Target: PIEZO1
• [Quantum Coherence Disruption in Cellular Communication](/hypothesis/h-4a31c1e0) — <span style="color:#ff8a65;font-weight:600">0.38</span> · Target: TUBB3

• [Microglia-astrocyte crosstalk amplification loops in neurodegeneration](/analysis/SDA-2026-04-01-gap-009) &#x1f504;